Sowell Financial Services LLC Zynerba Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.83 - $5.98 $172 - $269	-45 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$3.33 - $8.76 $41,741 - $109,806	-12,535 Reduced 99.64%	45 $0
Q4 2020 Jan 13, 2021	BUY	$3.27 - $4.64 $40,875 - $57,999	12,500 Added 15625.0%	12,580 $42,000
Q3 2020 Nov 12, 2020	SELL	$3.23 - $4.3 $7,374 - $9,816	-2,283 Reduced 96.61%	80 $0
Q2 2020 Aug 13, 2020	BUY	$3.31 - $6.54 $7,556 - $14,930	2,283 Added 2853.75%	2,363 $8,000
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $604 - $1,235	80 New	80 $1,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.